Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Zander

Showing results (371-380 of 456) with videos related to

Pageof 46
Sort By:
Annals of Hematology|May 3, 2003
Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemiaN Kröger, M Bornhäuser, G Ehninger, et al.
Leukemia|November 5, 2004
Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioningA Shimoni, N Kröger, T Zabelina, et al.
Bone Marrow Transplantation|May 1, 2012
Evaluation of BM cytomorphology after allo-SCT in patients with AMLM Christopeit, K Miersch, E Klyuchnikov, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 12, 2002
Highly efficient retroviral gene transfer based on centrifugation-mediated vector preloading of tissue culture vesselsKlaus Kühlcke, Boris Fehse, Andrea Schilz, et al.
Bone Marrow Transplantation|July 23, 1998
Busulfan, cyclophosphamide and etoposide as high-dose conditioning therapy in patients with malignant lymphoma and prior dose-limiting radiation therapyN Kröger, M Hoffknecht, M Hänel, et al.
Experimental Hematology|January 1, 1979
Autologous bone marrow transplantation in relapsed adult acute leukemiaK A Dicke, A R Zander, G Spitzer, et al.
Haematologica|March 1, 2002
Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host diseaseJohannes Schetelig, Nicolaus Kröger, Thomas K Held, et al.
Bone Marrow Transplantation|September 4, 2012
Evaluation of BM cytomorphology after allo-SCT in patients with MDSM Christopeit, S Ocheni, T Haferlach, et al.
Free Radical Biology & Medicine|May 10, 2000
Impaired plasma antioxidative defense and increased nontransferrin-bound iron during high-dose chemotherapy and radiochemotherapy preceding bone marrow transplantationM Dürken, C Herrnring, B Finckh, et al.
British Journal of Haematology|July 10, 2001
Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with anti-thymocyte globulinN Kröger, T Zabelina, W Krüger, et al.
Pageof 46

Showing results (371-380 of 456) with videos related to

Sort By:
Pageof 46
Annals of Hematology|May 3, 2003
Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemiaN Kröger, M Bornhäuser, G Ehninger, et al.
Leukemia|November 5, 2004
Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioningA Shimoni, N Kröger, T Zabelina, et al.
Bone Marrow Transplantation|May 1, 2012
Evaluation of BM cytomorphology after allo-SCT in patients with AMLM Christopeit, K Miersch, E Klyuchnikov, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 12, 2002
Highly efficient retroviral gene transfer based on centrifugation-mediated vector preloading of tissue culture vesselsKlaus Kühlcke, Boris Fehse, Andrea Schilz, et al.
Bone Marrow Transplantation|July 23, 1998
Busulfan, cyclophosphamide and etoposide as high-dose conditioning therapy in patients with malignant lymphoma and prior dose-limiting radiation therapyN Kröger, M Hoffknecht, M Hänel, et al.
Experimental Hematology|January 1, 1979
Autologous bone marrow transplantation in relapsed adult acute leukemiaK A Dicke, A R Zander, G Spitzer, et al.
Haematologica|March 1, 2002
Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host diseaseJohannes Schetelig, Nicolaus Kröger, Thomas K Held, et al.
Bone Marrow Transplantation|September 4, 2012
Evaluation of BM cytomorphology after allo-SCT in patients with MDSM Christopeit, S Ocheni, T Haferlach, et al.
Free Radical Biology & Medicine|May 10, 2000
Impaired plasma antioxidative defense and increased nontransferrin-bound iron during high-dose chemotherapy and radiochemotherapy preceding bone marrow transplantationM Dürken, C Herrnring, B Finckh, et al.
British Journal of Haematology|July 10, 2001
Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with anti-thymocyte globulinN Kröger, T Zabelina, W Krüger, et al.
Pageof 46